Behind the FDA Approval of Fruquintinib for Previously Treated mCRC
Season 4 Episode 18 · Nov 15, 2023, 03:45 PM
Share
Subscribe
In season 4, episode 18 of Targeted Talks, Arvind Dasari, MD, MS, dives into the recent approval of fruquintinib for patients with with metastatic colorectal cancer.